lax, My bigger point is that the label (no matter what country approves it) will become increasingly obsolete in its current form. Not right away obviously but given the off label use that is ALREADY occurring, and as the CV events are more understood there will be a general increase in earlier line use. I would bet on it.
btw, how do we get NRx/TRx reporting now? I emailed Biologics and asked if they published any such data.....silence.
News 
Market Data 
Discover 
AI
